Help Improve Outcomes
Prolonged inflammation doesn’t
help the Urology patient.
Clarix® is the answer.
Clarix 1K is a cryopreserved ultra-thick human birth tissue allograft used as an adjunct for surgical applications. Clarix 1K supports a regenerative healing environment and the restoration of urinary and sexual function after Robot-Assisted Radical Prostatectomy (RARP) by managing inflammation, managing adhesion formation, and facilitating soft tissue healing. 1-2
Start your journey with BioTissue today by filling out the form below:
Clarix is an ultra-thick allograft providing ease of use in robotic procedures.
Allograft placement over Neurovascular Bundles (NVBs) after prostate resection.
Introducing allograft into the surgical site using a single port robot.
Images courtesy of: Mutahar Ahmed, MD, Hackensack Meridian Health, Hackensack, NJ
The Proof is in the Evidence
Improved clinical outcomes are supported by our published clinical evidence in Oncological Urology applications:
83% of patients achieved continency at 3-months when Clarix was used as an adjunct in RARP.1
38% of patients achieved potency at 3-months post-RARP with the use of Clarix.2
Optimal Patient Outcomes Matter.
